Veeda unveils bio-analytical lab
Veeda Clinical Research has opened a state-of-the-art bio-analytical
laboratory at Ahmedabad, Gujarat. The new facility has been designed
using good laboratory practice (GLP) and good manufacturing practice
(GMP) requirements. This lab will be capable of housing up to 26
LC/MS/MS machines, and will be empowered with NuGenesis by Waters,
along with Watson LIMS by Thermo Scientific, which is already in use.
The new lab is equipped with dedicated areas such as high-end sample
processing, light sensitive area, special care area where controlled
conditions can be maintained for molecule specific requirements.
Veeda has plans to expand the existing clinical facility at Ahmedabad
across two phases, which would see the bed capacity in Ahmedabad
increase to 200. The first phase work is set to commence in October
2010, and will be ready by December 2010.
Acunova opens development center
Ecron Acunova, one of the leading CROs in India, launched its
Functional Services Center in Bangalore. This development center is
part of the growth plans of the company in the area of medical and
pharmacovigilance services. The launch will broaden Ecron Acunova’s
offering in drug safety services.
The center will employ 60 people initially, and will scale upto 200
people over the next two years. The center will focus on providing
pharmacovigilance, drug safety and clinical development programs like
protocol development, clinical study reports, narrative writing,
clinical quality control services and post marketing surveillance.
Speaking on the occasion, DA Prasanna, chairman & managing
director, Ecron Acunova, said, “The launch of the new center will
accelerate growth of the company in this emerging area of safety and
pharmacovigilance services. Our dedicated team of medical professionals
will help clients in developing risk assessment and safety
Quintiles opens global IT facility
Quintiles, a biopharmaceutical services company, has officially opened
its new Global Information Technology (IT) Service Operations Center in
Bangalore. The new center provides intelligent monitoring, control and
triage of system events across Quintiles’ technology cloud – its
shared, managed and secure computing environment. The center underpins
clinical research and commercialization operations for many globally
leading biopharmaceutical organizations.
The center at the Quintiles Bangalore campus in India, was opened in
the presence of Ashok Kumar, principal secretary-IT, Government of
Karnataka; Dr Ferzaan Engineer, CEO, Quintiles India; and Naz Haji,
senior vice president, Quintiles IT.
starts phase IV trial
A global pharmaceutical company has initiated a trial to evaluate the
impact of insulin guidelines developed by the Indian National Consensus
group in collaboration with Max Neeman, a leading contract research
organization. The goal is to provide simple management of type 2
diabetes patient dependent on insulin. The study will bring out a
comparison between the routine clinical practice and the therapy
decided as per the insulin guidelines. This large phase IV study
encompasses over 1,200 sites and aims to enroll over 25,000 type 2
tie up for drug discovery
TCG Lifesciences, India and Carna Biosciences, Japan have entered into
a strategic alliance to collaborate and provide jointly, high-end drug
discovery services focusing on kinase targets, to global pharma and
biotech companies. The companies expect to offer seamless services
through the drug discovery and development value chain, in selected
therapeutic areas which target on kinases.
Clinpharm launches On Trak
SIRO Clinpharm, a leading global contract research organization (CRO)
based in Mumbai, has launched On Trak, its clinical trial management
system. On Trak is part of a larger suite of Oracle Life Sciences
applications consisting Adverse Events Reporting System (AERS), Oracle
Clinical (OC), Remote Data Capture (RDC) and Thesaurus Management
System (TMS) that went live earlier.